Olaf G. Wilhelm

2.8k total citations
61 papers, 2.4k citations indexed

About

Olaf G. Wilhelm is a scholar working on Cancer Research, Hematology and Genetics. According to data from OpenAlex, Olaf G. Wilhelm has authored 61 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cancer Research, 28 papers in Hematology and 14 papers in Genetics. Recurrent topics in Olaf G. Wilhelm's work include Protease and Inhibitor Mechanisms (43 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Olaf G. Wilhelm is often cited by papers focused on Protease and Inhibitor Mechanisms (43 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Olaf G. Wilhelm collaborates with scholars based in Germany, United States and Netherlands. Olaf G. Wilhelm's co-authors include H. Graeff, Manfred Schmitt, Viktor Magdolen, Ute Reuning, Nadia Harbeck, Klaus T. Preissner, Peter A. Andreasen, Sandip M. Kanse, Heinz Höfler and Kurt Ulm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Olaf G. Wilhelm

60 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf G. Wilhelm Germany 28 1.6k 854 814 741 460 61 2.4k
Robert L. Cohen United States 14 840 0.5× 403 0.5× 1.2k 1.5× 528 0.7× 264 0.6× 23 2.2k
Matthias Kotzsch Germany 30 530 0.3× 607 0.7× 1.1k 1.3× 486 0.7× 210 0.5× 75 2.3k
Els Van Valckenborgh Belgium 36 677 0.4× 1.3k 1.5× 1.8k 2.2× 1.1k 1.5× 181 0.4× 77 2.9k
Carla A. Borgoño Canada 24 413 0.3× 735 0.9× 725 0.9× 785 1.1× 245 0.5× 31 2.3k
Corie N. Shrimpton United States 14 321 0.2× 897 1.1× 924 1.1× 243 0.3× 132 0.3× 21 2.1k
Emilia Fransvea Italy 25 730 0.5× 145 0.2× 1.5k 1.8× 1.1k 1.5× 675 1.5× 33 2.8k
Victoria Stepanova Russia 23 524 0.3× 339 0.4× 579 0.7× 171 0.2× 132 0.3× 45 1.4k
Birgit M. Kräling United States 10 551 0.4× 128 0.1× 986 1.2× 739 1.0× 164 0.4× 12 1.9k
Marina Molino Italy 16 399 0.3× 1.1k 1.3× 334 0.4× 206 0.3× 280 0.6× 19 1.9k
Johann Micallef Canada 10 1.5k 0.9× 130 0.2× 2.1k 2.6× 270 0.4× 137 0.3× 14 2.6k

Countries citing papers authored by Olaf G. Wilhelm

Since Specialization
Citations

This map shows the geographic impact of Olaf G. Wilhelm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf G. Wilhelm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf G. Wilhelm more than expected).

Fields of papers citing papers by Olaf G. Wilhelm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf G. Wilhelm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf G. Wilhelm. The network helps show where Olaf G. Wilhelm may publish in the future.

Co-authorship network of co-authors of Olaf G. Wilhelm

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf G. Wilhelm. A scholar is included among the top collaborators of Olaf G. Wilhelm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf G. Wilhelm. Olaf G. Wilhelm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilhelm, Olaf G., Christine Jordan, Amy W. Chung, et al.. (2025). Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets. Journal of Leukocyte Biology. 117(5). 1 indexed citations
2.
Napieralski, Rudolf, Gert Auer, Michaela Aubele, et al.. (2020). PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients. Breast Care. 16(5). 523–531. 4 indexed citations
3.
Schmitt, Manfred, Olaf G. Wilhelm, Aurelia Noske, et al.. (2018). Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy. Breast Care. 13(6). 425–433. 9 indexed citations
4.
Aubele, Michaela, Manfred Schmitt, Rudolf Napieralski, et al.. (2017). The Predictive Value ofPITX2DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges. Disease Markers. 2017. 1–14. 21 indexed citations
5.
Belldegrun, Arie S., Karim Chamie, Paul Bevan, et al.. (2013). ARISER: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC—Results and implications for adjuvant clinical trials.. Journal of Clinical Oncology. 31(15_suppl). 4507–4507. 37 indexed citations
6.
Schmiedeberg, Niko, Manfred Schmitt, Vincent Truffault, et al.. (2002). Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics. Journal of Medicinal Chemistry. 45(23). 4984–4994. 37 indexed citations
7.
Magdolen, Viktor, S. Sperl, Bernd Muehlenweg, et al.. (2002). Natural and Synthetic Inhibitors of The Tumor-Associated Serine Protease Urokinase-Type Plasminogen Activator. Advances in experimental medicine and biology. 477. 331–341. 14 indexed citations
8.
Lutz, Verena, Ute Reuning, Achim Krüger, et al.. (2001). High Level Synthesis of Recombinant Soluble Urokinase Receptor (CD87) by Ovarian Cancer Cells Reduces Intraperitoneal Tumor Growth and Spread in Nude Mice. Biological Chemistry. 382(5). 789–798. 17 indexed citations
9.
Koppitz, Marcus, Horst Kessler, Bernhard König, et al.. (1997). Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides. Biological Chemistry. 378(3-4). 231–7. 56 indexed citations
10.
Kanse, Sandip M., et al.. (1996). The Urokinase Receptor Is a Major Vitronectin-Binding Protein on Endothelial Cells. Experimental Cell Research. 224(2). 344–353. 219 indexed citations
11.
Wagner, Stephan N., Michael J. Atkinson, C. Wagner, et al.. (1996). Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochemistry and Cell Biology. 105(1). 53–60. 49 indexed citations
12.
Wilhelm, Sabine, Olaf G. Wilhelm, Martina Schmitt, & H. Graeff. (1994). Inactivation of Receptor-Bound Pro-Urokinase-Type Plasminogen Activator (pro-uPA) by Thrombin and Thrombin/Thrombomodulin Complex. Biological Chemistry Hoppe-Seyler. 375(9). 603–608. 12 indexed citations
13.
Kohnert, Ulrich, et al.. (1994). Tissue-Type Plasminogen Activator Domain-Deletion Mutant BM 06.022: Modular Stability, Inhibitor Binding, and Activation Cleavage. Biochemistry. 33(39). 11760–11766. 8 indexed citations
14.
Wilhelm, Olaf G., et al.. (1994). Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA). FEBS Letters. 337(2). 131–134. 92 indexed citations
15.
Wilhelm, Sabine, Olaf G. Wilhelm, Manfred Schmitt, et al.. (1993). Expression des Zelloberflächenrezeptors für Thrombin, Thrombomodulin, in humanen Ovarialkarzinomzellen. Gyn�kologisch-geburtshilfliche Rundschau. 33(1). 202–203. 1 indexed citations
16.
Bang, Nils U., Olaf G. Wilhelm, & Michael D. Clayman. (1992). Coronary Thrombolysis and Reperfusion - Literature Review and Future Projections. Seminars in Interventional Radiology. 9(3). 195–207. 1 indexed citations
17.
Vlahos, Chris J., Olaf G. Wilhelm, Tom Hassell, S. Richard Jaskunas, & Nils U. Bang. (1991). Disulfide pairing of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli. Journal of Biological Chemistry. 266(16). 10070–10072. 5 indexed citations
18.
Wilhelm, Olaf G., S. Richard Jaskunas, Chris J. Vlahos, & Nils U. Bang. (1990). Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.. Journal of Biological Chemistry. 265(24). 14606–14611. 27 indexed citations
19.
Bang, Nils U., Olaf G. Wilhelm, & Michael D. Clayman. (1989). After coronary thrombolysis and reperfusion, What next?. Journal of the American College of Cardiology. 14(4). 837–849. 28 indexed citations
20.
Wilhelm, Olaf G., R. Hafter, & H. Graeff. (1987). Fibrinolysis in ascitic fluid: Isolation and characterization of fibrin derivatives, their interaction with albumin. Thrombosis Research. 47(6). 673–681. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026